IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24...

Por Emery, P, Keystone, E, Tony, H P, Cantagrel, A, van Vollenhoven, R, Sanchez, A, Alecock, E, Lee, J, Kremer, J
Publicado em 2008

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Por Jones, G, Sebba, A, Gu, J, Lowenstein, M B, Calvo, A, Gomez-Reino, J J, Siri, D A, Tomšič, M, Alecock, E, Woodworth, T, Genovese, M C
Publicado em 2010